Ida Laurén

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks

Ibrahim, Eman; Laurén, Ida; Veerman, Rosanne E.; Jönsson, Siv et al.

Ingår i npj Precision Oncology, 2026

• DOI för Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
• Ladda ner fulltext (pdf) av Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks

Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange

Laurén, Ida; Kostakis, Alexandros; Lord, Martin; Björklund, Elvira et al.

Ingår i International Journal of Biological Macromolecules, 2026

• DOI för Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
• Ladda ner fulltext (pdf) av Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange

Next generation CD40 targeting immunotherapy: Development of antibody-based personalized cancer treatment

Laurén, Ida

2025

• Ladda ner fulltext (pdf) av Next generation CD40 targeting immunotherapy: Development of antibody-based personalized cancer treatment

A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice

Mebrahtu, Aman; Laurén, Ida; Veerman, Rosanne; Güclüler Akpinar, Gözde et al.

Ingår i Nature Communications, 2024

• DOI för A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice
• Ladda ner fulltext (pdf) av A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice

Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies

Eriksson, Camilla; Gunasekera, Sunithi; Muhammad, Taj; Zhang, Mingshu et al.

Ingår i ChemBioChem, 2023

• DOI för Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies
• Ladda ner fulltext (pdf) av Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies

Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks

Ibrahim, Eman; Laurén, Ida; Veerman, Rosanne E.; Jönsson, Siv et al.

Ingår i npj Precision Oncology, 2026

• DOI för Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks
• Ladda ner fulltext (pdf) av Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks

Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange

Laurén, Ida; Kostakis, Alexandros; Lord, Martin; Björklund, Elvira et al.

Ingår i International Journal of Biological Macromolecules, 2026

• DOI för Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
• Ladda ner fulltext (pdf) av Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange

A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice

Mebrahtu, Aman; Laurén, Ida; Veerman, Rosanne; Güclüler Akpinar, Gözde et al.

Ingår i Nature Communications, 2024

• DOI för A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice
• Ladda ner fulltext (pdf) av A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice

Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies

Eriksson, Camilla; Gunasekera, Sunithi; Muhammad, Taj; Zhang, Mingshu et al.

Ingår i ChemBioChem, 2023

• DOI för Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies
• Ladda ner fulltext (pdf) av Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies

An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies

Eltahir, Mohamed; Lauren, Ida; Lord, Martin; Chourlia, Aikaterini et al.

Ingår i Advanced Therapeutics, 2022

• DOI för An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
• Ladda ner fulltext (pdf) av An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies

Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

Tolf, Andreas; Wiberg, Anna; Müller, Malin; Nazir, Faisal Hayat et al.

Ingår i JAMA Network Open, 2022

• DOI för Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
• Ladda ner fulltext (pdf) av Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

Next generation CD40 targeting immunotherapy: Development of antibody-based personalized cancer treatment

Laurén, Ida

2025

• Ladda ner fulltext (pdf) av Next generation CD40 targeting immunotherapy: Development of antibody-based personalized cancer treatment